Parkinson's disease and cytokines

Cytokines

Volumn , Issue , 2011, Pages 343-356

  Iarlori, Carla ^a   Gambi, Domenico ^a   Reale, Marcella ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955282617     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (26)

1. Bessler, H. and R. Djaldetti, H. Salman, M. Bergman, and M. Djaldetti. 1999. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed. Pharmacother. 53: 141-145
2. Bialecka, M. and G. Klodowska-Duda, M. Kurzawski, J. Slawek, G. Opala, P. Bialecki, K. Safranow, and M. Drozdzik. 2007. Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch. Med. Res. 38: 858-863
3. Boka, G. and P. Anglade, D. Wallach, F. Javoy-Agid, Y. Agid, and E.C. Hirsch. 1994. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172: 151-154
4. Carvey, P.M. and E.Y. Chen, J.W. Lipton, C.W. Tong, Q.A. Chang, and Z.D. Ling. 2005. Intraparenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J. Neural. Transm. 112: 601-612
5. Clarke, D.J. and R.L. Branton. 2002. A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation. Exp. Neurol. 176: 154-162
6. Depino, A.M. and C. Earl, E. Kaczmarczyk, C. Ferrari, H. Besedovsky, A. del Rey, F.J. Pitossi, and W.H. Oertel. 2003. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 18: 2731-2742
7. Gayle, D.A. and Z. Ling, C. Tong, T. Landers, J.W. Lipton, and P.M. Carvey. 2002. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res. Dev. Brain Res. 133: 27-35
8. Gribova, I.E. and B.B. Gnedenko, V.V. Poleshchuk, and S.G. Morozov. 2003. Level of interferon-gamma, tumor necrosis factor alpha, and antibodies to them in blood serum from Parkinson disease patients. Biomed. Khim. 49: 208-212
9. Gruol, D.L. and T.E. Nelson. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15: 307-339
10. Hofmann, K.W. and A.F. Schumacher Schuh, J. Saute, R. Townsend, D. Fricke, R. Leke, D.O. Souza, L.V. Portela, M.L.F. Chaves, and C.R.M. Rieder. 2009. Interleukin-6 serum levels in patients with Parkinson's disease. Neurochem. Res. 34: 1401-1404
11. Imamura, K. and N. Hishikawa, M. Sawada, T. Nagatsu, M. Yoshida, and Y. Hashizume. 2003. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 106: 518-526
12. Mogi, M. and A. Togari, T. Kondo, Y. Mizuno, O. Komure, S. Kuno, H. Ichinose, and T. Nagatsu. 2000. Caspase activities and tumor necrosis factor receptor R1 level are elevated in the substantia nigra in Parkinson's disease. J. Neural. Transm. 107: 335-341
13. Mogi, M. and M. Harada, T. Kondo, P. Riederer, and T. Nagatsu. 1996a. Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. J. Neural. Transm. 103: 1077-1081
14. Mogi, M. and M. Harada, T. Kondo, Y. Mizuno, H. Narabayashi, P. Riederer, and T. Nagatsu. 1996. bcl-2 Protein is increased in the brain from parkinsonian patients. Neurosci. Lett. 215: 137-139
15. Nagatsu, T. and M. Mogi, H. Ichinose, and A. Togari. 2000. Cytokines in Parkinson's disease. J. Neural. Transm. Suppl. 58: 143-151
16. Nagatsu, T. and M. Sawada. 2005. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 11: 999-1016
17. Owen, A. and R.C. O'Neill, I. Maeve Rea, T. Lynch, D. Gosal, A. Wallace, P.M.D. Curran, D. Middleton, and J.M. Gibson. 2004. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Human Immunol. 65: 340-346
18. Pott Godoy, M.C. and R. Tarelli, C.C. Ferrari, M.I. Sarchi, and J. Fernando. 2008. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131: 1880-1894
19. Reale, M. and C. Iarlori, A. Thomas, D. Gambi, B. Perfetti, M. Di Nicola, and M. Onofrj. 2008. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun. 23: 55-63
20. Recchia, A. and P. Debetto, A. Negro, D. Guidolin, S.D. Skaper, and P. Giusti. 2004. Alphasynuclein and Parkinson's disease. FASEB J. 18: 617-626
21. Selikhova, M.V. and N.E. Kushlinskii, N.V. Lyubimova, and E.I. Gusev. 2002. Impaired production of plasma interleukin-6 in patients with Parkinson's disease. Bull. Exp. Biol. Med. 133: 81-83
22. Tweedie, D. and K. Sambamurti, and N.H. Greig. 2007. TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr. Alzheimer Res. 4: 378-385
23. Wahner, A.D. and J.S. Sinsheimer, J.M. Bronstein, and B. Ritz. 2007. Inflammatory cytokine gene polymorphisms and increased risk of parkinson disease. Arch. Neurol. 64: 836-840
24. Yucesoy, B. and V.J. Johnson, Mi.L. Kashon, and M.I. Luster. 2007. Cytokine polymorphisms and relationship to disease. pp. 113-132. In: Cytokines in Human Health. Immunotoxicology, Pathology, and Therapeutic Applications. Series: Methods in Pharmacology and Toxicology, Robert V. House and Jacques Descotes (eds.): DOI: 10.1007/978-1-59745-350-9-
25. Zhang, Y. and M. James, F.A. Middleton, and R.L. Davis. 2005. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137: 5-16
26. Zhang, Y. and M. James, F.A. Middleton, and R.L. Davis. 2005. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137: 5-16